Light and sound therapy for Alzheimer’s may also prevent ‘chemo brain’



Some cancer treatments cause what is known as chemo brain, generally defined as memory and concentration problems


An experimental treatment for Alzheimer’s disease that involves flickering lights and low-pitched sound may also help prevent cognitive problems after cancer treatment, sometimes called chemo brain, a study in mice suggests.

For Alzheimer’s disease, the light and sound stimulation has been shown to ease memory and concentration problems in small trials in people, but it is still being investigated in larger studies.

The lights flicker 40 times a second, or 40 hertz, with the sound also having a frequency of 40 Hz. This frequency was originally selected because people with Alzheimer’s have a lower intensity of 40 Hz brainwaves, which are linked with memory processing. The idea was that the treatment would stimulate these brainwaves.

Subsequent research suggests such brainwaves may result in broader benefits for the brain, including increasing the activity of immune cells and, most recently, boosting its drainage system, which could help clear a toxic protein called beta-amyloid.

Li-Huei Tsai at the Massachusetts Institute of Technology, who developed the approach, wondered if it could help people with cancer who experience memory and concentration problems after chemotherapy and other cancer treatments. It is thought these might be caused by damage to brain cells, but the exact mechanism is unclear and there are no treatments.

In the latest research, Tsai’s team found that mice exposed to the lights and sounds for 1 hour a day while being dosed with a common chemotherapy drug called cisplatin showed less of a decline in mental sharpness than those who just got the chemotherapy.

The treatment had several effects, including lowering brain inflammation, reducing DNA damage and lessening the loss of myelin, the insulation around nerve cell fibres.

Nazanin Derakhshan at the University of Reading in the UK says the idea needs to be tested in people to see if it provides an overall benefit. If the treatment were given at the same time as chemotherapy and it reduces cell death in the brain, that could promote the survival of cancer cells there, she says.



Source link

Related Posts